CHEK2 and neoplasm: Lastly, at the level of individual TCR interactions with recognized tumor cells, granzyme B release has been directly linked to DNA damage and associated CHK2 and p53 stress responses, and studies have demonstrated hSMG-1 stress-activated proteins upregulated in cancer cells following granzyme B treatment (Meslin et al., 2011).